Fig. 4From: Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidencesComparison of all-cause mortality between NOACs and warfarin stratified by each agent. A apixaban, B dabigatran, C edoxaban, and D rivaroxaban. CI = confidence interval, NOACs = non-vitamin K antagonist oral anticoagulantsBack to article page